e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Infection, sepsis and outcomes in ICU
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of ulinastatin in treatment of invasive candidiasis
S. Huang, X. Li, X. Guan (Guangzhou, China)
Source:
Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Session:
Infection, sepsis and outcomes in ICU
Session type:
Thematic Poster Session
Number:
2441
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Huang, X. Li, X. Guan (Guangzhou, China). Effects of ulinastatin in treatment of invasive candidiasis. Eur Respir J 2013; 42: Suppl. 57, 2441
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Indications and pitfalls of high-flow nasal cannula (HFNC) outside the intensive care unit
Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study
Problems and non-adherence to NIV in intensive care
Related content which might interest you:
Effect of N-acetylcysteine on the activity of antibiotics against relevant respiratory pathogens
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Benefits of co-administration of macrolides and glucocorticosteroids in the treatment of severe community acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016
Pulmonary actinomycosis: Successful treatment with oral antibiotics
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Outcomes of antioxidant administration in experimentally induced pneumonia
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Anti-inflammatory treatment
Source: International Congress 2017 – PG3 Bronchiectasis
Year: 2017
Non-steroidal anti-inflammatory drugs may worsen the course of community-acquired pneumonia : A cohort study
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016
Safety of intravenous amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
Atorvastatin as an anti inflammatory in bronchiectasis
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Breakthrough invasive pulmonary aspergillosis (IPA) in patients receiving posaconazole prophylaxis (PPxis)
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
The efficacy of adjuvant use low molecular weight heparins in patients with community-acquired pneumonia
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Antimicrobial susceptibility of pseudomonasaeruginosa in CF patients before and after regular treatment with inhaled tobramycin
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015
Comparison of three modalities of corticosteroids administration in chronic rhinosinusitis
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
Empirical treatment of community-acquired pneumonia after outpatient beta-lactam therapy
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Modification of empirical antibiotic therapy in community acquired pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Development of an antibody therapy for the treatment of pneumonia
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
N-acetylcysteine potentiates surfactant therapy for experimental meconium aspiration syndrome
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Investigation of gram positive antibiotics as aerosol administration (cubicin, vancomycin, zyvoxid)
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
A 12-week combination of clarithromycin and prednisone for the treatment of cryptogenic and radiation-induced organising pneumonia
Source: International Congress 2015 – New insights into IIPs
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept